Healthcare

Clarity Pharmaceuticals (ASX:CU6) is a clinical-stage developer rather than an established seller of approved medicines. Its proprietary sarcophagine, or SAR, platform is designed to securely hold radioactive copper isotopes within molecules directed at particular cancer targets. Copper-64 supports diagnostic positron emission tomography (PET) imaging; …

Australian Clinical Labs Limited (ASX:ACL) operates pathology laboratories and collection centres across Australia, providing clinical diagnostics to general practitioners, specialists and hospitals. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The …

Imricor Medical Systems Inc. (ASX:IMR) develops medical devices designed to support cardiac electrophysiology procedures performed inside magnetic resonance imaging environments. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of …

Artrya Limited (ASX:AYA) develops software that applies artificial intelligence to coronary computed tomography angiography, with a focus on helping clinicians evaluate coronary artery disease. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence …

Clinuvel Pharmaceuticals Limited (ASX:CUV) develops and commercialises pharmaceutical products for serious skin disorders, including the photoprotective treatment SCENESSE. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of the business …

Healius Limited (ASX:HLS) provides pathology services through a network of laboratories and collection centres serving Australian patients and referring practitioners. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of …

Racura Oncology Limited (ASX:RAC) is a clinical-stage oncology developer advancing RC220, a formulation of bisantrene, across several cancer treatment programs. Its operations sit within healthcare, where clinical standards, regulatory requirements and the practical needs of hospitals, clinicians or patients influence delivery. The nature of …